Chauhan, VM;
Zhang, H;
Dalby, PA;
Aylott, JW;
(2020)
Advancements in the co-formulation of biologic therapeutics.
Journal of Controlled Release
, 327
pp. 397-405.
10.1016/j.jconrel.2020.08.013.
Preview |
Text
1-s2.0-S0168365920304533-main.pdf - Published Version Download (1MB) | Preview |
Abstract
Biologic therapeutics are the medicines of the future and are destined to transform the approaches by which the causes and symptoms of diseases are cured and alleviated. These approaches will be accelerated through the development of novel strategies that target multiple pharmacologically active sites using a combination of different biologics, or mixtures of biologics and small molecule therapeutics. However, for this potential to be realised, advancements in co-formulation strategies for biologic therapeutics must be established. This review describes the current and emerging developments within this field and highlights the challenges and potential solutions, that will pave-the-way towards their clinical translation.
| Type: | Article |
|---|---|
| Title: | Advancements in the co-formulation of biologic therapeutics |
| Location: | Netherlands |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1016/j.jconrel.2020.08.013 |
| Publisher version: | https://doi.org/10.1016/j.jconrel.2020.08.013 |
| Language: | English |
| Additional information: | © 2020 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/) |
| Keywords: | Biologics, Co-formulation, Combination therapy, Nucleic acid, Protein, Synergistic benefit, Vaccine |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > UCL BEAMS UCL > Provost and Vice Provost Offices > UCL BEAMS > Faculty of Engineering Science UCL > Provost and Vice Provost Offices > UCL BEAMS > Faculty of Engineering Science > Dept of Biochemical Engineering |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10109088 |
Archive Staff Only
 |
View Item |
